Lorlatinib

CAS 1454846-35-5

In Stock

Lorlatinib

Cat. No. ANT-LRL-000CAS 1454846-35-5In Stock

Technical Data

Cat. No.ANT-LRL-000

CAS1454846-35-5

Mol. FormulaC₂₁H₁₉FN₆O₂

Mol. Weight406.42 g/mol

IUPAC(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile

SMILESC[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C

InChIInChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1

InChI KeyIIXWYSCJSQVBQM-LLVKDONJSA-N

Purity99%

Description

Overview

Lorlatinib works to stop cancer cells from growing to treat non-small cell lung cancer

Anant Labs manufacture and furnish high quality Lorlatinib impurities for global markets. Our Lorlatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

(R)-26-amino-55-fluoro-11,4,7-trimethyl-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrileLorlatinib1454846-35-5PF-06463922LoratinibLorbrenaPF06463922lorlatinibumOSP71S83EU2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-

Browse APIs A–Z